While VEGF-C and VEGF-D mainly promote development of lymphatic vessels, VEGF-A165 (commonly termed VEGF) is the master regulator of angiogenesis in peripheral circulation as well as in most pathologies associated to aberrant vascular growth, such as cancer and blinding eye disorders [24,156]. Here, VEGFA is linked to cancer.